Cargando…

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management

Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in the general population. PFO has been associated with the paradoxical embolism causing cryptogenic stroke and systemic embolization. Results from clinical trials, meta-analyses, and position papers support percutan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucà, Fabiana, Pino, Paolo G., Parrini, Iris, Di Fusco, Stefania Angela, Ceravolo, Roberto, Madeo, Andrea, Leone, Angelo, La Mair, Mark, Benedetto, Francesco Antonio, Riccio, Carmine, Oliva, Fabrizio, Colivicchi, Furio, Gulizia, Michele Massimo, Gelsomino, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004032/ https://www.ncbi.nlm.nih.gov/pubmed/36902748 http://dx.doi.org/10.3390/jcm12051952

Ejemplares similares

Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
por: Parrini, Iris, et al.
Publicado: (2020)

Evaluation of Patent Foramen Ovale in Young Adults with Cryptogenic Stroke
por: Ali Ebrahimi, Hossein, et al.
Publicado: (2011)

Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to Close?
por: Kottoor, Santhosh J, et al.
Publicado: (2018)

Cryptogenic stroke and patent foramen ovale (abridged and translated version)
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
por: Gollion, Cédric, et al.
Publicado: (2022)

The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023)

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
por: Tanislav, Christian, et al.
Publicado: (2010)

Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013)

Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017)

Cryptogenic Stroke and Significance of the Patent Foramen Ovale: A Case Series
por: Pour-Ghaz, Issa, et al.
Publicado: (2018)

Characteristics and prognosis of patients with cryptogenic stroke and suggestive of patent foramen ovale
por: Choi, Jaehuk, et al.
Publicado: (2021)

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks
por: Pino, Paolo G., et al.
Publicado: (2023)

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
por: Yuan, Kristy, et al.
Publicado: (2018)

Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
por: Sadrameli, Saeed S, et al.
Publicado: (2018)

Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019)

Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022)

Increased Incidence of Interatrial Block in Younger Adults with Cryptogenic Stroke and Patent Foramen Ovale
por: Cotter, P.E., et al.
Publicado: (2011)

Cryptogenic stroke over 60 years of age: should patent foramen ovale be closed?
por: Gaspardone, Achille, et al.
Publicado: (2020)

May-Thurner Syndrome and Patent Foramen Ovale: A Rare Etiology of Cryptogenic Stroke
por: Phelps, Benjamin J, et al.
Publicado: (2019)

Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
por: Poli, Sven, et al.
Publicado: (2021)

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

Early Recurrent Ischemic Lesions in Patients With Cryptogenic Stroke and Patent Foramen Ovale: An Observational Study
por: Braemswig, Tim Bastian, et al.
Publicado: (2018)

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?
por: Vemulapalli, Sreekanth, et al.
Publicado: (2018)

Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding?
por: Ioannidis, Stefanos G., et al.
Publicado: (2020)

Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?
por: ARBOIX, Adrià, et al.
Publicado: (2021)

Treatment Strategies for Cryptogenic Stroke Patients with Patent Foramen Ovale: What Do We Choose?
por: Shen, Yu, et al.
Publicado: (2021)

Histology of Cerebral Clots in Cryptogenic Stroke Varies According to the Presence of a Patent Foramen Ovale
por: Härtl, Johanna, et al.
Publicado: (2022)

Managing Patent Foramen Ovale (PFO) in Adults With Cryptogenic Stroke and Lymphoma: A Multidisciplinary Perspective
por: Khalid, Noman, et al.
Publicado: (2023)

Patent foramen ovale closure
por: Amin, Zahid
Publicado: (2010)

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
por: Mir, Hassan, et al.
Publicado: (2018)

Unexpected early migration of a patent foramen ovale occluder
por: Mair, Johannes, et al.
Publicado: (2021)

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study
por: Tanislav, Christian, et al.
Publicado: (2011)

Cryptogenic Stroke Associated With Patent Foramen Ovale in a Collegiate Volleyball Athlete: A Case Report
por: Miyazawa, Aimee, et al.
Publicado: (2010)

Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale
por: Spencer, Frederick A, et al.
Publicado: (2014)

Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial
por: Shariat, Abdolhamid, et al.
Publicado: (2013)

Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK
por: Von Klemperer, Katherine, et al.
Publicado: (2017)

How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke
por: Falanga, Gabriella, et al.
Publicado: (2015)

Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale
por: Caglar, Fatma Nihan Turhan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sd4kd0ogu03b1kaamtf9fedee7